FSA
Fort Sheridan Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $555K | Hold |
1,701
| – | – | 0.08% | 146 |
|
|
2025
Q1 | $459K | Hold |
1,701
| – | – | 0.07% | 165 |
|
|
2024
Q4 | $400K | Sell |
1,701
-32
| -2% | -$7.53K | 0.06% | 180 |
|
|
2024
Q3 | $477K | Hold |
1,733
| – | – | 0.07% | 155 |
|
|
2024
Q2 | $421K | Buy |
+1,733
| New | +$421K | 0.07% | 165 |
|
|
2024
Q1 | – | Sell |
-1,078
| Closed | -$206K | – | 207 |
|
|
2023
Q4 | $206K | Buy |
+1,078
| New | +$206K | 0.04% | 187 |
|
|
2023
Q3 | – | Sell |
-1,078
| Closed | -$205K | – | 195 |
|
|
2023
Q2 | $205K | Hold |
1,078
| – | – | 0.05% | 188 |
|
|
2023
Q1 | $216K | Buy |
+1,078
| New | +$216K | 0.05% | 179 |
|